Welcome to DailyUpdates Diagnostics & Devices - the R&D community's bulletin of breaking research, clinical trials and drug development news. This page will update each day. You have access for 2 more day(s). To receive DailyUpdates by e-mail register here

PubMed DailyUpdates: Breaking Scientific Publications for the Drug Discovery Community

DailyUpdates by e-mail - the publication tracker for the drug discovery community

Diagnostics & Devices

If this icon appears after any of our listed articles, the author is able to provide reprints. Articles denoted by an Licensing Op. icon describe data relevant to licensing opportunities. The report icon, , links through to full analyses relating to pharmaceutical/market developments relating to this work


Today's journal articles

No journal articles today

Do you need further information on any of the agents being evaluated in the trial(s) below?  Let us know...

New Clinical Trials

No clinical trials today

Previous Journal Entries

Differential levels of p75NTR ectodomain in CSF and blood in patients with Alzheimer's disease: a novel diagnostic marker.

Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice.

Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.

MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.

Toward point-of-care testing for JAK2 V617F mutation on a microchip.

Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.

Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.

Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).

A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.

IL-17a and IL-21 combined with surgical status predict the outcome of ovarian cancer patients.

Activated Pak4 expression correlates with poor prognosis in human gastric cancer patients.

Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer.

Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.

Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening.

Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.

The Development of a Continuous Intravascular Glucose Monitoring Sensor.

Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.

Serum soluble CD40 ligand levels after acute intracerebral hemorrhage.

Prognostic impact of CD109 expression in myxofibrosarcoma.

Today's News Items

The World’s First Smart Insulin Pens with Automatic Wireless Data Transfer (868 MHz or Bluetooth®)

Training Courses & Meetings

No events listed

Previous News Items

Asuragen’s QuantideX® qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance for Monitoring Minimal Residual Disease in Chronic Myeloid Leukemia